Immunohistochemistry baseline patterns identified for the cases where efficacy data were obtained
| Case | EGFR | pEGFR | PMAPK | pAkt |
|---|---|---|---|---|
| Learning set | ||||
| 198 | ++ | + | ++ | + |
| 410 | ++ | + | ++ | + |
| 286 | ++ | − | ++ | − |
| 140 | − | − | + | − |
| 163 | + | − | − | − |
| 287 | + | − | + | − |
| 253 | + | − | + | − |
| 194 | − | − | + | − |
| 265 | ++ | − | ++ | + |
| 215 | + | − | ++ | − |
| Validation set | ||||
| 219 | + | − | ++ | + |
| 294 | − | − | ++ | − |
| 281 | + | − | + | − |
| 247 | + | − | ++ | + |
| 185 | ++ | − | ++ | − |
| 159 | ++ | − | + | − |
| 354 | − | − | ++ | + |
| 420 | ++ | − | ++ | − |
NOTE: Sensitive cases are shown in bold.